• SENSEX 73,257.62
    -341.05 (--0.46%)
  • BANKNIFTY 53,974.90
    -391.80 (--0.72%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,161.90 1,152.30(%)
  • Piramal Pharma
    235.45 231.85(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    189.95 227.00(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Cholaman.Inv.&Fn
    1,555.00 1,952.00(%)
  • Acutaas Chemical
    3,690.00 1,571.20(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • One 97
    1,640.50 1,856.50(%)
  • Ola Electric
    37.44 51.84(%)
  • Sahajanand Medi
    482.10 347.50(%)
  • Bajaj Finance
    918.00 1,177.60(%)
  • Swiggy
    183.05 174.30(%)
  • Infosys
    1,103.50 980.30(%)
  • Patanjali Foods
    352.00 613.95(%)
  • Netweb Technol.
    4,490.00 5,810.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fermenta Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 146.0
  • ISIN : INE225B01021
447.65 1 (0.13%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    442.25

  • Today’s High

    464.20

  • Open

    442.65

  • Perv Close

    447.05

  • 52W Low

    248.85

  • 52W High

    582.65

Key Indicators

  • P/E(TTM)

    22.86

  • Mar.Cap (₹Cr.)

    1,317.48

  • Div & Yield %

    0.81

  • Book Value(₹)

    143.79

  • Debt-Equity Ratio

    0.13

  • AGM Date

    27-Oct-2026

  • EPS

    19.64

  • P/E Ratio

    22.86

Financials Ratios

  • Debt-Equity Ratio

    0.59

  • Mar.Cap (₹Cr.)

    1,317.48

  • RONW (%)

    -5.82

  • ROCE (%)

    2.96

Score Board

  • Equity (₹ in Cr.)

    14.72

  • BV (₹)

    143.80

  • Sales( ₹ in Cr.)

    450.25

  • NP (in Cr.)

    55.23

  • NP Var(%)

    -23.0

  • Div%

    75.0

  • CPS (₹)

    25.90

  • EPS (₹)

    18.80

  • Traded Value (₹ in Lakhs)

    1,321.45

  • 52 Week High

    582.65

  • 52 Week Low

    248.85

  • Price BSE

    449.0

  • Price NSE

    448.00

  • Market Capital( in Cr.)

    1,321.45

  • P/C Ratio

    17.30

  • P/E Ratio

    23.90

  • Price Vs.BV

    18.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 450.25 430.53 307.09 328.91 387.96 372.82
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 450.25 430.53 307.09 328.91 387.96 372.82
Other Income 30.87 11.68 8.15 8.46 7.53 6.62
Stock Adjustments 24.71 7.59 -13.86 -17.29 -7.65 15.88
Total Income 505.83 449.80 301.38 320.08 387.84 395.32
EXPENDITURE :            
Raw Materials 178.07 154.38 91.57 109.21 136.55 139.52
Power and Fuel Cost 29.13 27.23 19.78 18.24 20.35 14.23
Employee Cost 74.14 60.10 53.93 53.81 59.36 57.50
Other Manufacturing Expenses 45.58 48.84 50.29 44.12 43.65 36.06
Selling and Administration Expenses 49.13 39.08 34.46 38.73 38.16 37.25
Miscellaneous Expenses 7.24 7.74 14.87 68.12 5.42 9.41
Employee Benefit Expenses 74.14 60.10 53.93 53.81 59.36 57.50
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 383.27 337.37 264.90 332.23 303.50 293.96
Operating Profit 122.56 112.43 36.49 -12.14 84.35 101.36
Interest 12.38 14.84 17.40 21.35 18.11 19.10
Gross Profit 110.18 97.59 19.09 -33.49 66.24 82.26
Depreciation 20.94 23.17 23.70 24.49 23.67 19.03
Profit Before Tax 89.24 74.42 -4.61 -57.98 42.57 63.23
Current Tax 14.61 13.12 14.14 -0.97 7.41 11.26
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 10.35 -6.32 0.00 0.00 4.92 0.00
Reported Net Profit 64.28 67.62 -18.74 -57.00 30.24 51.97
Extraordinary Items 9.05 -4.09 -11.01 -60.09 -0.02 -0.13
Adjusted Net Profit 55.23 71.71 -7.73 3.09 30.26 52.10
Adjustment below Net Profit 0.24 -0.80 0.12 9.52 -0.24 -0.04
P & L Balance brought forward 340.00 276.80 299.03 350.72 327.93 275.99
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 7.29 3.61 3.61 4.20 7.21 0.00
P & L Balance carried down 397.24 340.00 276.80 299.03 350.72 327.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 75.00 50.00 25.00 25.00 25.00 50.00
Dividend Per Share(Rs) 3.75 2.50 1.25 1.25 1.25 2.50
Earnings Per Share-Unit Curr 22.42 23.18 -6.49 -19.75 10.48 18.01
Earnings Per Share(Adj)-Unit Curr 22.42 23.18 -6.49 -19.75 10.48 18.01
Book Value 147.47 130.26 108.83 116.45 137.26 128.42
Book Value(Adj)-Unit Curr 147.47 130.26 108.83 116.45 137.26 128.42

Shareholding Pattern

  • Promoter Group

    60.12%

  • Public Share Holding

    37.49%

  • Custodian

    2.39%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1,074,438 1,074,438.00 1,074,438 1,074,438
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1,074,438 3.65 1,074,438 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,620,633 56.47 16,620,633 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,620,633 56.47 16,620,633 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 120 0.00 120 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 309,313 1.05 309,313 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 386 0.00 386 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 309,819 1.05 309,819 7
2] Non Institution
Bodies Corporate 540,857 1.84 540,257 140
Clearing Members 23,114 0.08 23,114 14
Directors of their Relatives 125,577 0.43 125,577 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 230,770 0.78 230,770 426
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 293,882 1.00 293,882 455
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,076,107 10.45 3,076,107 22
Individuals holding nominal share capital up to Rs. 1 lakh 6,074,088 20.64 5,891,179 14,996
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 224,117 0.76 224,117 3
Sub Total 10,722,461 36.43 10,538,952 16,072
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 703,636 2.39 703,636 1
Total Shares held by Custodians and against which Depository Receipts have been issued 703,636 2.39 703,636 1
Grand Total ( A + B + C ) 29,430,987 100.00 29,247,478 16,084

Company Background

Fermenta Biotech LtdPharmaceuticals - Indian - Bulk Drugs

  • Fermenta Biotech Ltd
  • BSE Code : 146.0
  • ISIN : INE225B01021

  • Incorporation Year

    1951

  • Registered Office

    A-1501 DIL Complex Majiwada
    Ghodbunder Road Thane One, Thane (West),
    Maharashtra-400610

  • Telephone

    91-22-66230800/888

  • FAX

    91-22-67980899

  • Chairman

    Pradeep Manjunath Chandan

  • Managing Director

    Prashant Nagre

  • Company Secretary

  • Auditor

    S R B C & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Fermenta Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fermenta Biotec. 449.00 474.15 450.25 20.96 18.77
Abbott India 25,488.50 7,217.19 6,929.05 33.54 43.78
Astrazeneca Phar 6,073.10 2,304.07 2,275.58 89.51 27.86
Sanofi India 3,066.25 1,857.10 1,837.40 21.81 54.17
Glaxosmi. Pharma 2,488.75 3,932.76 3,790.20 39.76 58.17
Novartis India 1,847.40 393.10 354.33 46.65 15.94
Cipla 1,350.00 20,102.60 18,979.95 41.15 13.88
Bliss GVS Pharma 643.55 773.53 729.81 59.81 12.51
Amrutanjan Healt 490.45 520.13 502.55 26.27 24.16
Guj. Themis Bio. 352.45 168.25 165.82 94.24 18.05
Ambalal Sarabhai 35.40 19.52 3.94 65.56 6.77